About Pivotal bioVenture Partners
Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. They invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. They invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. Their team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biotechnology, Healthcare, VR/AR
Investor Type
Venture Capital
Investment Focus
Focus Areas
Investment Stages